Clinics in Dermatology
Volume 24, Issue 4 , Pages 276-280 , July 2006

Addison's disease

  • Lynnette K. Nieman, MD

      Affiliations

    • Reproductive and Biology Medicine Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 301 496 8935; fax: +1 301 402 0884.
    • ,
  • Maria L. Chanco Turner, MD

      Affiliations

    • Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA

References 

  1. Addison T. On the constitutional and local effects of diseases of the supra-renal capsules. London: Warren and Son; 1855;
  2. Tsatmali M, Ancans J, Yukitake J, Thody AJ. Skin POMC peptides: their actions at the human MC-1 receptor and roles in the tanning response. Pigment Cell Res. 2000;13(Suppl 8):125–129
  3. Dunlop D. Eighty-six cases of Addison's disease. BMJ. 1963;5362:887–891
  4. Nieman LK. Dynamic evaluation of adrenal hypofunction. J Endocrinol Invest. 2003;26(7 Suppl):74–82
  5. Simpson SL. Addison's disease. BMJ. 1950;4689:1164–1166
  6. Sanford JP, Favour CB. The interrelationships between Addison's disease and active tuberculosis: a review of 125 cases of Addison's disease. Ann Intern Med. 1956;45:56–72
  7. Piedrola G, Casado JL, Lopez E, et al. Clinical features of adrenal insufficiency in patients with acquired immunodeficiency syndrome. Clin Endocrinol (Oxf). 1996;45:97–101
  8. Ihde JK, Turnbull AD, Bajourunas DR. Adrenal insufficiency in the cancer patient: implications for the surgeon. Br J Surg. 1990;77:1335–1337
  9. Rao RH, Vagnucci AH, Amico JA. Bilateral massive adrenal hemorrhage: early recognition and treatment. Ann Intern Med. 1989;110:227–235
  10. Kong MF, Jeffcoate W. Eighty-six cases of Addison's disease. Clin Endocrinol (Oxf). 1994;41:757–761
  11. Ahonen P, Myllarnieini S, Sipila I, Perheentupu J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990;322:1829–1836
  12. Betterle C, Volpato M, Greggio AN, Presotto F. Type 2 polyglandular autoimmune disease (Schmidt's syndrome). J Pediatr Endocrinol Metab. 1996;9(Suppl 1):113–123
  13. Rizzo WB. X-linked adrenoleukodystrophy: a cause of primary adrenal insufficiency in males. Endocrinologist. 1992;2:177–183
  14. Bergner GE, Eisenstein AB. Addison's disease in the negro. J Clin Endocrinol Metab. 1951;11:322–329
  15. Bor S, Feiwel M, Chanarin I. Vitiligo and its aetiological relationship to organ-specific autoimmune disease. Br J Dermatol. 1969;81:83–88
  16. Grinspoon SK, Biller BM. Clinical review 62: laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab. 1994;79:923–931
  17. Laureti S, Aubourg P, Calcinaro F, et al. Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers. J Clin Endocrinol Metab. 1998;83:3163–3168
  18. Moser AB, Kreiter N, Bezman L, et al. Plasma very long chain fatty acids in 3000 peroxisome disease patients and 29,000 controls. Ann Neurol. 1999;45:100–110
  19. Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. 1999;341:1013–1020
  20. Libe R, Barbetta L, Dall'Asta C, et al. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism. J Endocrinol Invest. 2004;27:736–741
  21. Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. JAMA. 2002;287:236–240
  22. Oelkers W, L'age M. Control of mineralocorticoid substitution in Addison's disease by plasma renin measurement. Klin Wochenschr. 1976;54:607–612

PII: S0738-081X(06)00044-7

doi: 10.1016/j.clindermatol.2006.04.006

Clinics in Dermatology
Volume 24, Issue 4 , Pages 276-280 , July 2006

Article Tools

* Image Usage & Resolution